Carregant...
Why should we monitor for hematologic adverse drug reactions to oxcarbazepine?
Guardat en:
| Publicat a: | Korean J Pediatr |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Korean Pediatric Society
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6702119/ https://ncbi.nlm.nih.gov/pubmed/31319648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3345/kjp.2019.00472 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|